---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-200650"
form_type: "8-K"
ticker: "WAT"
cik: "0001000697"
company_name: "WATERS CORP /DE/"
filed_at: "2024-08-14T23:59:59+00:00"
generated_at: "2026-05-31T09:13:24.247145+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Waters Corporation appoints Heather Knight to Board of Directors

## Summary
- Appointed Heather Knight effective Aug 14, 2024; Board size increased from 9 to 10.
- Knight is EVP and Group President, Medical Products and Therapies at Baxter International.
- Initial equity grant valued at $91,666 (50% RSU, 50% option), vesting on first anniversary.
- Prorated cash retainer of $54,130 until 2025 AGM; standard non-employee director compensation.
- Knight brings nearly three decades of global pharma and med device leadership experience.

## SEC filing metadata
- accession: 0001193125-24-200650
- form_type: 8-K
- ticker: WAT
- cik: 0001000697
- company_name: WATERS CORP /DE/
- filed_at: 2024-08-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1000697/000119312524200650/0001193125-24-200650-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1000697/000119312524200650/d879337d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-200650
- JSON: https://secwatch.observer/filing/0001193125-24-200650.json
- Plain text: https://secwatch.observer/filing/0001193125-24-200650.txt

## Key facts
- Executive change
  Heather Knight was appointed as director at WATERS CORP /DE/.
  - Action: appointed
  - Role: director
  source text: On August 13, 2024, the Board of Directors (the “Board”) of Waters Corporation (the “Company”) increased the size of the Board from 9 to 10 members and appointed Heather Knight to the Board, effective August 14, 2024, to fill the vacancy so created.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1000697/000119312524200650/0001193125-24-200650-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.